NCT06313736

What SSI Duration is Most Effective? An Online Experiment With American Adults

How Long Should a Behavioral Activation Single-session Intervention be? A Four-armed Trial Comparing Effectiveness by Intervention Duration
Northwestern University·ClinicalTrials.gov·behavioralRecruitment Completed
View on ClinicalTrials.gov
Study focus
Disease/Condition
Depression
Drug/Device/Intervention
Action Brings Change Project (15-minute adult version)
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Northwestern University
Location
Chicago, United States of America
Timeline & enrollment
Phase
N/A
Start date
Mar 20, 2024
End date
May 01, 2024
Enrollment
1100 participants
Primary outcome

Change in Patient Health Questionnaire-8 at 8 weeks (PHQ-8; Kroenke et al., 2009)

Summary

In a previous study (https://osf.io/qdznc), the research team found that an 8-minute version
 of a single-session intervention for loneliness was more effective than a 23-minute version
 of it. The present work aims to further explore the relationship between intervention
 duration and effectiveness.
 
 In this online trial, participants will be randomized to a 15-minute single-session
 depression intervention called the Action Brings Change (ABC) Program, a 10-minute version of
 it, a 6-minute version of it, or a 2-minute version of it. The main analysis will evaluate
 how change in depressive symptoms over eight weeks differs across conditions.

ICD-10 classifications
Depressive episodeOther depressive episodesRecurrent depressive disorderRecurrent depressive disorder, unspecifiedPost-schizophrenic depression
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06313736
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06313736 through Pure Global AI's free database. This phase not specified trial is sponsored by Northwestern University and is currently Recruitment Completed. The study focuses on Depression. Target enrollment is 1100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.